Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic
dc.date.accessioned | 2020 | |
dc.date.available | 2020 | |
dc.date.issued | 2020 | |
dc.identifier.govdoc | PAHO/NMH/NV/COVID-19/20-0029 | |
dc.identifier.uri | https://iris.paho.org/handle/10665.2/52477 | |
dc.description.abstract | Appropriate and adequate management of people with noncommunicable diseases (NCDs) includes access to essential NCD medicines. Disrupted access to chronic medication for hypertension, diabetes, heart disease, mental health disorders, cancer, and asthma could result in severe disease exacerbation and potentially death. | en_US |
dc.language.iso | en | en_US |
dc.publisher | PAHO | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 IGO | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/igo/ | * |
dc.subject | COVID-19 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Diabetes Mellitus | en_US |
dc.subject | Heart Diseases | en_US |
dc.subject | Mental Health | en_US |
dc.subject | Asthma | en_US |
dc.subject | Risk Factors | en_US |
dc.subject | Vulnerable Populations | en_US |
dc.title | Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic | en_US |
dc.type | Fact sheets | en_US |
dc.rights.holder | Pan American Health Organization | en_US |
dc.contributor.corporatename | Pan American Health Organization | en_US |
paho.isfeatured | 0 | en_US |
paho.publisher.country | United States | en_US |
paho.publisher.city | Washington, D.C. | en_US |
paho.source.centercode | US1.1 | en_US |
paho.relation.languageVersion | 10665.2/52582 | |
paho.contributor.department | Noncommunicable Diseases and Mental Health (NMH) | en_US |
paho.iswhotranslation | No | en_US |